Results 251 to 260 of about 468,283 (304)

Evaluating the effectiveness of AI-enhanced "One Body, Two Wings" pharmacovigilance models in China: a nationwide survey on medication safety and risk management. [PDF]

Front Health Serv
Yang J, Sun Y, Li F, Wei Q, Wei J, Zhang Y.   +5 more
europepmc   +1 more source

Regulatory-required post-marketing database studies in Japan could be leveraged to assess important potential risks as well as identified risks. [PDF]

Front Pharmacol
Yamazaki H, Nakajo K, Hirose N, Yan L, Lee SY, Zhang Y, Qiu H, Ishiguro C.   +7 more
europepmc   +1 more source

Market pathways to food systems transformation toward healthy and equitable diets through convergent innovation. [PDF]

Nat Commun
Struben J, Chan D, Talukder B, Dubé L.
europepmc   +1 more source

Utilization of Evidence Blueprint Initiative to Transform Capability Development in AstraZeneca Spain. [PDF]

Pharmaceut Med
Medina J, Sánchez-Covisa J, Nuevo J, Palacios B, Roncero A, Alegría M, Gostkorzewicz J, Velasco A, Larsen K, Moreno M, Velasco C, Pérez Domínguez A.   +11 more
europepmc   +1 more source

Health Care Professionals' Experiences Regarding Facilitators of and Barriers to Sustained Use of Social Robot Ivy for People With Intellectual Disabilities: Qualitative Interview Study.

J Med Internet Res
Steins M, Huijnen C, Odekerken-Schröder G, Mahr D, Mennens K, Daniels R, Mathmann F.   +6 more
europepmc   +1 more source

The Persuasive Power of LLMs: A Systematic Literature Review and Meta-Analysis

Hölbling L, Maier S, Feuerriegel S.
europepmc   +1 more source